בלנרפ
glaxo smith kline (israel) ltd - belantamab mafodotin - אבקה להכנת תמיסה מרוכזת לעירוי - belantamab mafodotin 100 mg - belantamab
פרינמיה
a.l. medi-market ltd. - iron iii as iron iii hydroxide sucrose complex - iron iii as iron iii hydroxide sucrose complex 20 mg / 1 ml - saccharated iron oxide
פברזיים 35 מג
sanofi israel ltd - agalsidase beta - אבקה להכנת תמיסה מרוכזת לעירוי - agalsidase beta 35 mg/vial - agalsidase beta - agalsidase beta - fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease. (alfa - galactosidase a deficiency).
אמיודקור זריקות
sanofi israel ltd - amiodarone hydrochloride - תמיסה להזרקה - amiodarone hydrochloride 50 mg / 1 ml - amiodarone - amiodarone - corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.
סנדוסטטין 30 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 30 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective.endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.
סנדוסטטין 20 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 20 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.
סנדוסטטין 10 מג lar
novartis israel ltd - octreotide - אבקה וממס להכנת תרחיף להזרקה - octreotide 10 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.
סיגניפור לאר 20 מג
medison pharma ltd - pasireotide as embonate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as embonate 20 mg/vial - pasireotide
סיגניפור לאר 40 מג
medison pharma ltd - pasireotide as embonate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as embonate 40 mg/vial - pasireotide
סיגניפור לאר 60 מג
medison pharma ltd - pasireotide as embonate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as embonate 60 mg/vial - pasireotide